New therapies for Crohn's disease are being developed based on improvements in our understanding of the disease's immune and inflammatory properties. One of these new therapies is infliximab, a monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha. Recent studies indicate that treatment of moderately to severely ill Crohn's disease patients with infliximab produces a rapid and profound reduction in the signs, symptoms, and severity of this disease. Beyond its clinical impact, Crohn's disease also carries significant economic consequences. Earlier reports on the costs of managing this disease estimated the average annual medical costs per patient at $9197, with the total annual cost of illness estimated to exceed $1.7 billion. Hospitalizations and surgeries represented 80% of these costs. Additional analyses have been conducted for this review to reflect more current treatment patterns. Assuming that proven increases in response and remission rates lead to diminished disease severity, infliximab can be expected to reduce the number of hospitalizations and surgeries in moderately to severely ill patients, with substantial cost savings. Moreover, improvement in disease status and quality of life may allow Crohn's disease patients to lead more productive lives.

Antibodies, Monoclonal↗

PubMedDate not supplied

Alexithymia may influence the diagnosis of coronary heart disease.

A number of psychosomatic studies have suggested that alexithymia, impairment in identifying and expressing inner feelings, might somehow affect the course of various illnesses. However, none of these studies have distinguished between an impact of alexithymia on actual pathophysiological change versus an impact only on illness behavior. In the present study, a population-based random sample of 2297 middle-aged men from Eastern Finland was evaluated for alexithymia using the Finnish version of the self-report Toronto Alexithymia Scale (TAS). Although high TAS scores were associated with prior diagnosis of coronary heart disease (CHD), they were not associated with greater prevalence of ischemia on an exercise tolerance test. The results of B-mode ultrasonography of the carotid artery for those who had a CHD diagnosis showed that carotid atherosclerosis actually decreased significantly as alexithymia increased. An interaction analysis indicated that alexithymia was related to increased probability of being diagnosed with CHD only among those who had mildly or moderately progressed carotid atherosclerosis, and not among those with the most severe progression. Alexithymia was associated with higher perceived exertion, and to some extent, with more self-reported symptoms during the exercise tolerance test. The findings support the hypothesis that alexithymia relates to increased symptom reporting rather than pathophysiological changes in CHD. The results also suggest that alexithymic men may get diagnosed earlier, perhaps because of their different illness behavior.

Adult↗

PubMedDate not supplied

Hopelessness and risk of mortality and incidence of myocardial infarction and cancer.

We examined the relationship among low, moderate, and high levels of hopelessness, all-cause and cause-specific mortality, and incidence of myocardial infarction (MI) and cancer in a population-based sample of middle-aged men. Participants were 2428 men, ages 42 to 60, from the Kuopio Ischemic Heart Disease study, an ongoing longitudinal study of unestablished psychosocial risk factors for ischemic heart disease and other outcomes. In 6 years of follow-up, 174 deaths (87 cardiovascular and 87 noncardiovascular, including 40 cancer deaths and 29 deaths due to violence or injury), 73 incident cancer cases, and 95 incident MI had occurred. Men were rated low, moderate, or high in hopelessness if they scored in the lower, middle, or upper one-third of scores on a 2-item hopelessness scale. Age-adjusted Cox proportional hazards models identified a dose-response relationship such that moderately and highly hopeless men were at significantly increased risk of all-cause and cause-specific mortality relative to men with low hopelessness scores. Indeed, highly hopeless men were at more than three-fold increased risk of death from violence or injury compared with the reference group. These relationships were maintained after adjusting for biological, socioeconomic, or behavioral risk factors, perceived health, depression, prevalent disease, or social support. High hopelessness also predicted incident MI, and moderate hopelessness was associated with incident cancer. Our findings indicate that hopelessness is a strong predictor of adverse health outcomes, independent of depression and traditional risk factors. Additional research is needed to examine phenomena that lead to hopelessness.

Adult↗

PubMedDate not supplied

Bicarbonate therapy and lactic acidosis.

Explore the source record for details and available documents.

Acidosis↗

PubMedDate not supplied

Psychosocial factors in the natural history of physical activity.

We studied the association between demographic, socioeconomic, and psychosocial factors and change in level of physical activity in 4,025 persons who were interviewed in 1965 and 1974 as part of the Alameda County study. Relative declines in physical activity were found to be associated with education level (less than a college education), race (being black or non-white [women]), low income, blue-collar occupation, unmarried status, group non-membership, social isolation, depression, personal uncertainty (women), low life satisfaction, and health perceived less than "excellent." These results demonstrate the multifactorial determination of level of physical activity.

Adolescent↗

PubMedDate not supplied

Smoking and body mass in the natural history of physical activity: prospective evidence from the Alameda County Study, 1965-1974.

The prospective effects of smoking status and body mass on change in leisure-time physical activity from 1965 to 1974 were examined in a cohort of 4,622 persons 20-94 years of age from the Alameda County Study. With adjustment for age and baseline physical activity, current smokers showed a greater nine-year decline in leisure-time physical activity than those who had never smoked. The coefficient for current smokers from a multivariate linear regression model was of a similar magnitude among women and men (coefficient = -0.27, 95% confidence interval [CI] = -0.50 to -0.05 for women; coefficient = -0.26, 95% CI = -0.54 to 0.02 for men). Larger declines in physical activity were seen with increasing number of current pack-years exposure among both women and men. Compared with women of average body mass index, women of heaviest body mass index had larger declines (coefficient = -0.70, 95% CI = -1.04 to -0.36) while women of the lightest body mass index had larger increases (or smaller declines) in physical activity (coefficient = 0.33, 95% CI = 0.00 to 0.66). Although body mass index did not initially appear to be associated with a change in physical activity among men, age-specific analyses indicated that the effect of body mass index on physical activity varied with age such that younger (20-39 years of age), thinner men increased their activity, while older (60 years of age and over), thinner men decreased their physical activity more than men of the same age with average body mass index.

Adolescent↗